title: Low-Molecular-Weight Heparin in the Initial Treatment of Proximal Deep Vein Thrombosis.
abstract: Intravenous unfractionated heparin followed by oral warfarin is the current standard of care for the treatment of acute venous thrombosis. More recently, several low-molecular-weight heparin preparations have been shown to be as effective and safe as unfractionated heparin for the initial therapy of acute proximal vein thrombosis. These drugs have a number of advantages over unfractionated heparin, and will undoubtedly replace the current standard for the initial treatment of venous thromboembolism.
authors.affiliation: Clinical Trials Unit, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
authors.initials: KA
authors.lastname: Valentine
authors.initials: GF
authors.lastname: Pineo
authors.initials: RD
authors.lastname: Hull